Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

Alternative promoters drive human cytomegalovirus reactivation from latency.

Collins-McMillen D, Rak M, Buehler JC, Igarashi-Hayes S, Kamil JP, Moorman NJ, Goodrum F.

Proc Natl Acad Sci U S A. 2019 Aug 27;116(35):17492-17497. doi: 10.1073/pnas.1900783116. Epub 2019 Aug 13.

PMID:
31409717
2.

Pathogen at the Gates: Human Cytomegalovirus Entry and Cell Tropism.

Nguyen CC, Kamil JP.

Viruses. 2018 Dec 11;10(12). pii: E704. doi: 10.3390/v10120704. Review.

3.

The Human Cytomegalovirus Endoplasmic Reticulum-Resident Glycoprotein UL148 Activates the Unfolded Protein Response.

Siddiquey MNA, Zhang H, Nguyen CC, Domma AJ, Kamil JP.

J Virol. 2018 Sep 26;92(20). pii: e00896-18. doi: 10.1128/JVI.00896-18. Print 2018 Oct 15.

4.

Human Cytomegalovirus Tropism Modulator UL148 Interacts with SEL1L, a Cellular Factor That Governs Endoplasmic Reticulum-Associated Degradation of the Viral Envelope Glycoprotein gO.

Nguyen CC, Siddiquey MNA, Zhang H, Li G, Kamil JP.

J Virol. 2018 Aug 29;92(18). pii: e00688-18. doi: 10.1128/JVI.00688-18. Print 2018 Sep 15.

5.

Expression Levels of Glycoprotein O (gO) Vary between Strains of Human Cytomegalovirus, Influencing the Assembly of gH/gL Complexes and Virion Infectivity.

Zhang L, Zhou M, Stanton R, Kamil J, Ryckman BJ.

J Virol. 2018 Jul 17;92(15). pii: e00606-18. doi: 10.1128/JVI.00606-18. Print 2018 Aug 1.

6.

Recent advances in CMV tropism, latency, and diagnosis during aging.

Leng SX, Kamil J, Purdy JG, Lemmermann NA, Reddehase MJ, Goodrum FD.

Geroscience. 2017 Jun;39(3):251-259. doi: 10.1007/s11357-017-9985-7. Epub 2017 Jul 5.

7.

Preparation of the Human Cytomegalovirus Nuclear Egress Complex and Associated Proteins.

Sharma M, Kamil JP, Coen DM.

Methods Enzymol. 2016;569:517-26. doi: 10.1016/bs.mie.2015.08.020. Epub 2015 Sep 11.

8.

Viral Regulation of Cell Tropism in Human Cytomegalovirus.

Li G, Kamil JP.

J Virol. 2015 Nov 11;90(2):626-9. doi: 10.1128/JVI.01500-15. Print 2016 Jan 15. Review.

9.

Genotypic assessment of drug-resistant tuberculosis in Baghdad and other Iraqi provinces using low-cost and low-density DNA microarrays.

Al-Rubaye DS, Henihan G, Al-Abasly AK, Seagar AL, Al-Attraqchi AA, Schulze H, Hashim DS, Kamil JK, Laurenson IF, Bachmann TT.

J Med Microbiol. 2016 Feb;65(2):114-22. doi: 10.1099/jmm.0.000203. Epub 2015 Nov 10.

PMID:
26555649
10.

A viral regulator of glycoprotein complexes contributes to human cytomegalovirus cell tropism.

Li G, Nguyen CC, Ryckman BJ, Britt WJ, Kamil JP.

Proc Natl Acad Sci U S A. 2015 Apr 7;112(14):4471-6. doi: 10.1073/pnas.1419875112. Epub 2015 Mar 23.

11.

Human cytomegalovirus resistance to deoxyribosylindole nucleosides maps to a transversion mutation in the terminase subunit-encoding gene UL89.

Gentry BG, Phan Q, Hall ED, Breitenbach JM, Borysko KZ, Kamil JP, Townsend LB, Drach JC.

Antimicrob Agents Chemother. 2015 Jan;59(1):226-32. doi: 10.1128/AAC.03686-14. Epub 2014 Oct 27.

12.

Human cytomegalovirus UL97 phosphorylates the viral nuclear egress complex.

Sharma M, Bender BJ, Kamil JP, Lye MF, Pesola JM, Reim NI, Hogle JM, Coen DM.

J Virol. 2015 Jan;89(1):523-34. doi: 10.1128/JVI.02426-14. Epub 2014 Oct 22.

13.

An epistatic relationship between the viral protein kinase UL97 and the UL133-UL138 latency locus during the human cytomegalovirus lytic cycle.

Li G, Rak M, Nguyen CC, Umashankar M, Goodrum FD, Kamil JP.

J Virol. 2014 Jun;88(11):6047-60. doi: 10.1128/JVI.00447-14. Epub 2014 Mar 12.

14.

Antimicrobial and antiradical activity of extracts obtained from leaves of three species of the genus pyrus.

Zbigniew S, Beata Ż, Kamil J, Roman F, Barbara K, Andrzej D.

Microb Drug Resist. 2014 Aug;20(4):337-43. doi: 10.1089/mdr.2013.0155. Epub 2014 Mar 12.

PMID:
24621262
15.

Human cytomegalovirus UL50 and UL53 recruit viral protein kinase UL97, not protein kinase C, for disruption of nuclear lamina and nuclear egress in infected cells.

Sharma M, Kamil JP, Coughlin M, Reim NI, Coen DM.

J Virol. 2014 Jan;88(1):249-62. doi: 10.1128/JVI.02358-13. Epub 2013 Oct 23.

16.

Resistance of human cytomegalovirus to cyclopropavir maps to a base pair deletion in the open reading frame of UL97.

Gentry BG, Vollmer LE, Hall ED, Borysko KZ, Zemlicka J, Kamil JP, Drach JC.

Antimicrob Agents Chemother. 2013 Sep;57(9):4343-8. doi: 10.1128/AAC.00214-13. Epub 2013 Jul 1.

17.

The ULb' region of the human cytomegalovirus genome confers an increased requirement for the viral protein kinase UL97.

Wang D, Li G, Schauflinger M, Nguyen CC, Hall ED, Yurochko AD, von Einem J, Kamil JP.

J Virol. 2013 Jun;87(11):6359-76. doi: 10.1128/JVI.03477-12. Epub 2013 Mar 27.

18.

Inactivation of retinoblastoma protein does not overcome the requirement for human cytomegalovirus UL97 in lamina disruption and nuclear egress.

Reim NI, Kamil JP, Wang D, Lin A, Sharma M, Ericsson M, Pesola JM, Golan DE, Coen DM.

J Virol. 2013 May;87(9):5019-27. doi: 10.1128/JVI.00007-13. Epub 2013 Feb 20.

19.

Marek's disease viral interleukin-8 promotes lymphoma formation through targeted recruitment of B cells and CD4+ CD25+ T cells.

Engel AT, Selvaraj RK, Kamil JP, Osterrieder N, Kaufer BB.

J Virol. 2012 Aug;86(16):8536-45. doi: 10.1128/JVI.00556-12. Epub 2012 May 30.

20.

Sites and roles of phosphorylation of the human cytomegalovirus DNA polymerase subunit UL44.

Silva LA, Strang BL, Lin EW, Kamil JP, Coen DM.

Virology. 2011 Sep 1;417(2):268-80. doi: 10.1016/j.virol.2011.06.008. Epub 2011 Jul 23.

21.

HATs on for drug resistance.

Kamil JP, Coen DM.

Cell Host Microbe. 2011 Feb 17;9(2):85-7. doi: 10.1016/j.chom.2011.02.001.

23.

Stereoselective phosphorylation of cyclopropavir by pUL97 and competitive inhibition by maribavir.

Gentry BG, Kamil JP, Coen DM, Zemlicka J, Drach JC.

Antimicrob Agents Chemother. 2010 Aug;54(8):3093-8. doi: 10.1128/AAC.00468-10. Epub 2010 Jun 14.

24.

Human papillomavirus 16 E7 inactivator of retinoblastoma family proteins complements human cytomegalovirus lacking UL97 protein kinase.

Kamil JP, Hume AJ, Jurak I, Münger K, Kalejta RF, Coen DM.

Proc Natl Acad Sci U S A. 2009 Sep 29;106(39):16823-8. doi: 10.1073/pnas.0901521106. Epub 2009 Sep 15.

25.

Viral mimicry of Cdc2/cyclin-dependent kinase 1 mediates disruption of nuclear lamina during human cytomegalovirus nuclear egress.

Hamirally S, Kamil JP, Ndassa-Colday YM, Lin AJ, Jahng WJ, Baek MC, Noton S, Silva LA, Simpson-Holley M, Knipe DM, Golan DE, Marto JA, Coen DM.

PLoS Pathog. 2009 Jan;5(1):e1000275. doi: 10.1371/journal.ppat.1000275. Epub 2009 Jan 23.

26.

Phosphorylation of retinoblastoma protein by viral protein with cyclin-dependent kinase function.

Hume AJ, Finkel JS, Kamil JP, Coen DM, Culbertson MR, Kalejta RF.

Science. 2008 May 9;320(5877):797-9. doi: 10.1126/science.1152095.

27.

Human cytomegalovirus protein kinase UL97 forms a complex with the tegument phosphoprotein pp65.

Kamil JP, Coen DM.

J Virol. 2007 Oct;81(19):10659-68. Epub 2007 Jul 18. Erratum in: J Virol. 2007 Dec;81(23):13277.

28.

Horizontal transmission of Marek's disease virus requires US2, the UL13 protein kinase, and gC.

Jarosinski KW, Margulis NG, Kamil JP, Spatz SJ, Nair VK, Osterrieder N.

J Virol. 2007 Oct;81(19):10575-87. Epub 2007 Jul 18.

29.

A virus-encoded telomerase RNA promotes malignant T cell lymphomagenesis.

Trapp S, Parcells MS, Kamil JP, Schumacher D, Tischer BK, Kumar PM, Nair VK, Osterrieder N.

J Exp Med. 2006 May 15;203(5):1307-17. Epub 2006 May 1.

30.

Marek's disease virus: from miasma to model.

Osterrieder N, Kamil JP, Schumacher D, Tischer BK, Trapp S.

Nat Rev Microbiol. 2006 Apr;4(4):283-94. Review.

PMID:
16541136
31.

vLIP, a viral lipase homologue, is a virulence factor of Marek's disease virus.

Kamil JP, Tischer BK, Trapp S, Nair VK, Osterrieder N, Kung HJ.

J Virol. 2005 Jun;79(11):6984-96.

32.

Chitosan as an edible invisible film for quality preservation of herring and atlantic cod.

Jeon YJ, Kamil JY, Shahidi F.

J Agric Food Chem. 2002 Aug 28;50(18):5167-78.

PMID:
12188625
33.

Retroviral insertion into herpesviruses: discovery and implications.

Kung HJ, Kamil J, Witter R, Davidson I.

Dev Biol (Basel). 2001;106:223-8; discussion 228-9, 253-63.

PMID:
11761235
34.

Variations in treatment benefits influence smoking cessation: results of a randomised controlled trial.

Schauffler HH, McMenamin S, Olson K, Boyce-Smith G, Rideout JA, Kamil J.

Tob Control. 2001 Jun;10(2):175-80.

35.

The complete unique long sequence and the overall genomic organization of the GA strain of Marek's disease virus.

Lee LF, Wu P, Sui D, Ren D, Kamil J, Kung HJ, Witter RL.

Proc Natl Acad Sci U S A. 2000 May 23;97(11):6091-6.

36.

Executives with white coats--managed-care medical directors.

Belman MJ, Kamil J.

N Engl J Med. 2000 May 4;342(18):1370-1. No abstract available.

PMID:
10798948

Supplemental Content

Support Center